Turn off MathJax
Article Contents
ZHANG Yao, ZHAO Chengjun, REN Bin, DU Lei, MA Qianyuan. Research Progress on Liver Failure and Prognosis Models after Radical Resection of Hepatocellular Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0235
Citation: ZHANG Yao, ZHAO Chengjun, REN Bin, DU Lei, MA Qianyuan. Research Progress on Liver Failure and Prognosis Models after Radical Resection of Hepatocellular Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2023-0235

Research Progress on Liver Failure and Prognosis Models after Radical Resection of Hepatocellular Carcinoma

doi: 10.12290/xhyxzz.2023-0235

2021 Qinghai Province "Kunlun Talents · High-end innovative and entrepreneurial talents" funding

  • Available Online: 2023-07-25
  • The classical Child-Pugh classification and the Model for End-Stage Liver Disease (MELD) are now widely used clinically for preoperative assessment of liver failure and prognosis in patients with hepatocellular carcinoma (HCC) treated with radical hepatectomy. However, there are limitations in the conditions of use of both due to factors such as albumin, ascites, and blood creatinine. Review the relevant literature at home and abroad about liver failure and prognosis of HCC patients after radical Hepatectomy: albumin bilirubin score (ALBI), platelet albumin bilirubin score (PALBI), Glasgow Prognostic Score (GPS) and new predictive models have good application prospects in evaluating liver failure and prognosis of HCC patients after Hepatectomy. Combined with the literature, the study of the classic, new liver function scores and new predictive models after Hepatectomy in HCC patients shows that the PALBI score has good application value at present.
  • loading
  • [1] Forner A, Reig M, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2018, 391:1301-1314.
    [2] Villanueva A. Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380:1450-1462.
    [3] Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease:the major impact of China[J]. Hepatology, 2014, 60:2099-2108.
    [4] Shen YH, Sun HC, Zhou J. Evaluation of liver reserve function before hepatectomy[J/CD]. Chinese J Hepat Surg (Electronic Edition), 2019, 8:469-472. 沈英皓, 孙惠川, 周俭. 肝切除术前肝脏储备功能评估[J]. 中华肝脏外科手术学电子杂志, 2019, 8:469-472.
    [5] Yu DC, Chen WB, Jiang CP, et al. Risk assessment in patients undergoing liver resection[J]. Hepatobiliary Pancreat Dis Int, 2013, 12:473-479.
    [6] Byrd K, Alqahtani S, Yopp AC, et al. Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma[J]. Semin Liver Dis, 2021, 41:1-8.
    [7] National Health Commission of the People's Republic of China. Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)[J]. Chin J Hepatol, 2022, 30:367-388. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版)[J]. 中华肝脏病杂志, 2022, 30:367-388.
    [8] Zhou SJ, Zhang EL, Liang BY, et al. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis[J]. J Surg Res, 2016, 200:444-451.
    [9] Watanabe Y, Aikawa M, Kato T, et al. Influence of Child-Pugh B7 and B8/9 cirrhosis on laparoscopic liver resection for hepatocellular carcinoma:a retrospective cohort study[J]. Surg Endosc, 2023, 37:1316-1333.
    [10] Durand F, Valla D. Assessment of the prognosis of cirrhosis:Child-Pugh versus MELD[J]. J Hepatol, 2005, 42:S100-S107.
    [11] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31:864-871.
    [12] Badawy A, Seo S, Toda R, et al. Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma:which is the best?[J]. ANZ J Surg, 2019, 89:1275-1280.
    [13] Wang YY,Zhao XH, Ma L, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118:440-445.
    [14] Chen MQ, Li WT, Liu XG, et al. Application value of new liver function scoring models in radiofrequency ablation for hepatocellular carcinoma[J]. J Clin Hepatol, 2020, 36:2092-2096. 陈敏强, 李文韬, 刘晓光, 等. 新型肝功能评分模型在肝细胞癌射频消融治疗中的应用价值[J]. 临床肝胆病杂志, 2020, 36:2092-2096.
    [15] Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma:a new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33:550-558.
    [16] Fagenson AM, Gleeson EM, Pitt HA, et al. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes[J]. J Am Coll Surg, 2020, 230:637-645.
    [17] Lin CY, Lin CC, Wang CC, et al. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection[J]. World J Surg, 2020, 44:247-257.
    [18] Marasco G, Alemanni LV, Colecchia A, et al. Prognostic Value of the AlbuminBilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure:A Systematic Review and Meta-Analysis[J]. J Clin Med, 2021, 10:2011.
    [19] Wang YY, Zhong JH, Su ZY, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma[J]. Br J Surg, 2016, 103:725-734.
    [20] Lau W, Leung K, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice[J]. Ann Surg, 1997, 225:281-285.
    [21] Roayaie S, Jibara G, Berhane S, et al. PALBI An objective score based on platelets,albumin bilirubin stratifies HCC patients undergoing resection & ablation better than child's classification[J].Hepatology,2015,62(Suppl 1):624A-690A.
    [22] Lu LH, Zhang YF, Cai MY, et al. Platelet-albumin-bilirubin grade:Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma[J]. Dig Liver Dis, 2019, 51:1430-1437.
    [23] Luo HM, Zhao SZ, Li C, et al. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection:A retrospective study[J]. Medicine (Baltimore), 2018, 97:e0226.
    [24] Shehta A, Han HS, Ahn S, et al. Post-resection recurrence of hepatocellular carcinoma in cirrhotic patients:Is thrombocytopenia a risk factor for recurrence?[J]. Surg Oncol, 2016, 25:364-369.
    [25] Maithel SK, Kneuertz PJ, Kooby DA, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma:a multi-institutional analysis[J]. J Am Coll Surg, 2011, 212:638-648.
    [26] Wang ZX, Peng W, Zhang XY, et al. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy[J]. Medicine (Baltimore), 2021, 100:e24476.
    [27] Omichi C, Nakamura K, Haraga J, et al. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer[J]. Cancer Med, 2016, 5:1074-1080.
    [28] Kumamoto T, Takeda K, Matsuyama R, et al. Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy[J]. Anticancer Res, 2023, 43:875-882.
    [29] Kaibori M, Hiraoka A, Iida H, et al. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma:A Multicenter Retrospective Study in Japan[J]. Cancers (Basel), 2022, 14:2091.
    [30] Chang KV, Chen JD, Wu WT, et al. Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma:A Systematic Review and Meta-Analysis[J]. Liver Cancer, 2018,7:90-103.
    [31] Liu PH, Hsu CY, Hsia CY, et al. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era[J]. J Gastroenterol Hepatol, 2017, 32:879-886.
    [32] Sonohara F, Yamada S, Tanaka N, et al. Comparison of non-invasive liver reserve and fibrosis models:Implications for surgery and prognosis for hepatocellular carcinoma[J]. Hepatol Res, 2019, 49:1305-1315.
    [33] Jaruvongvanich V, Sempokuya T, Linda W, et al. Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?[J]. J Gastrointest Oncol, 2018, 9:750-761.
    [34] Liao Y, Wei R, Yao RZ, et al. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients:a retrospective study[J]. BMC Surg, 2021, 21:72.
    [35] Zhang J, Luo Y, Li C, et al. The combination of the preoperative albuminbilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection[J]. Biosci Trends, 2019, 13:351-357.
    [36] Liao R, Li DW, Du CY, et al. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy[J]. J Gastrointest Surg, 2018, 22:1679-1687.
    [37] Luo H, Li C, Chen LP, et al. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection[J]. Biosci Trends, 2019, 13:176-181.
    [38] Pereyra D, Rumpf B, Ammann M, et al. The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy[J]. Ann Surg Oncol, 2019, 26:791-799.
    [39] Kaibori M, Hiraoka A, Matsui K, et al. Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed NeoGlasgow Prognostic Score with ALBI Grade:Comparison of Open and Laparoscopic Surgery Cases[J]. Cancers (Basel), 2022, 14:1402.
    [40] Bray F, Ferlay J, Soerjomataram L, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2020, 70:313.
    [41] Wang Q, Su B, Dong LW, et al. Liquid Chromatography-Mass SpectrometryBased Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection[J]. J Proteome Res, 2020, 19:3533-3541.
    [42] Fang C, Su B, Jiang TY, et al. Prognosis prediction of hepatocellular carcinoma after surgical resection based on serum metabolic profiling from gas chromatography-mass spectrometry[J]. Anal Bioanal Chem, 2021, 413:3153-3165.
    [43] Yu LX, Schwabe RF. The gut microbiome and liver cancer:mechanisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14:527-539.
    [44] Wu L, Feng J, Li JJ, et al. The gut microbiome-bile acid axis in hepatocarcinogenesis[J]. Biomed Pharmacother, 2021, 133:111036.
    [45] Saillard C, Schmauch B, Laifa O, et al. Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides[J]. Hepatology, 2020, 72:2000-2013.
    [46] Wong GL, Hui VW, Tan QX, et al. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis[J]. JHEP Rep, 2022, 4:100441.
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (48) PDF downloads(8) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint